# Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome

> **NCT04137692** · NA · SUSPENDED · sponsor: **Weill Medical College of Cornell University** · enrollment: 12 (estimated)

## Conditions studied

- Glucose Transporter Type 1 Deficiency Syndrome
- GLUT1DS1

## Interventions

- **OTHER:** Red Blood Cell Transfusion

## Key facts

- **NCT ID:** NCT04137692
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2027-09
- **Primary completion:** 2030-08
- **Final completion:** 2031-08
- **Target enrollment:** 12 (ESTIMATED)
- **Why stopped:** PI is transferring institutions.
- **Last updated:** 2025-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04137692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04137692, "Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04137692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*